Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer. In expanding its drug development efforts in the field of cancer through its proprietary targeted cancer programs, Curis is building upon its previous experiences in targeting signaling pathways for the development of next generation targeted cancer therapies.
Type
Public
HQ
Lexington, US
Founded
2000
Size (employees)
44 (est)
Curis was founded in 2000 and is headquartered in Lexington, US

Curis Office Locations

Curis has office in Lexington
Lexington, US

Curis Metrics

Curis Summary

Market capitalization

$417.2 m

Closing share price

$3
Curis's current market capitalization is $417.2 m.

Curis Financials

Curis's revenue is $15 m in FY, 2013 which is a 52.4% increase from the previous period.
FY, 2013FY, 2014FY, 2015Y, 2016

Revenue

$15 m$9.8 m$7.9 m$7.5 m

Revenue growth, %

(34.4%)(20%)(4.5%)

Net Income

($12.3 m)($18.7 m)($59 m)

Curis Market Value History

Curis Company Life

You may also be interested in